Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : NVO source : Www.biospace.com save search
Ventus Therapeutics Announces Results from Phase 1 Clinical Trial of VENT-02, a Novel, Orally Administered, Brain-Penetrant NLRP3 Inhibitor
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: 1.22%
H: 0.21%
C: -0.34%
vent-02 trial therapeutics results
Ventus Therapeutics to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference
Published: 2024-04-08 (Crawled : 12:30) - biospace.com/
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: 1.62%
H: 0.5%
C: 0.36%
conference therapeutics
Novo Holdings to Acquire Catalent
Published: 2024-02-05 (Crawled : 12:00) - biospace.com/
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: 2.37%
H: 1.9%
C: 1.61%
MS | News 0 d | $90.08 1.06% -0.28% 9.5M
|
Finance
|
| O: -0.79%
H: 0.0%
C: -0.8%
CTLT | $55.96 0.32% 0.0% 1.9M
|
Health Technology
|
| O: 8.81%
H: 1.5%
C: 0.86%
acquire
Cleveland Diagnostics Completes $75M Financing to Advance its Early-detection Oncology Testing Platform
Published: 2024-01-17 (Crawled : 14:30) - biospace.com/
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: -0.03%
H: 0.75%
C: 0.34%
diagnostics platform
Nalu Medical, Inc. Announces $65 Million Equity Financing to Advance Treatment for Chronic Neuropathic Pain
Published: 2024-01-03 (Crawled : 17:00) - biospace.com/
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: -0.06%
H: 1.75%
C: 1.54%
million treatment
Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi
Published: 2023-12-19 (Crawled : 08:00) - biospace.com/
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: 0.91%
H: 0.72%
C: 0.11%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.45%
H: 0.0%
C: 0.0%
IPHA | $2.35 -9.27% -10.21% 16K
|
Health Technology
|
| O: 13.88%
H: 0.0%
C: -3.58%
pharma natural cell sanofi
MapLight Therapeutics Closes $225 Million Series C Funding Round to Advance Pipeline of Central Nervous System Therapeutics
Published: 2023-10-30 (Crawled : 18:00) - biospace.com/
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: 3.44%
H: 0.71%
C: -0.33%
pipeline series system therapeutics funding
Vect-Horus Enters Exclusive License Agreement with Novo Nordisk to Develop Targeted Therapeutics
Published: 2023-10-30 (Crawled : 14:00) - biospace.com/
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: 3.44%
H: 0.71%
C: -0.33%
license therapeutics agreement
Orexo announces changes in the company´s Board of Directors - October 27, 2023
Published: 2023-10-27 (Crawled : 08:00) - biospace.com/
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: -1.5%
H: 0.78%
C: -0.29%
Cytoki Pharma Presents Preclinical Data Demonstrating Weight Reduction and Improved Glucose Control with Lipidated IL-22 at ObesityWeek 2023
Published: 2023-10-16 (Crawled : 19:00) - biospace.com/
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: -0.84%
H: 0.19%
C: -0.13%
il-22 obesityweek pharma control preclinical
FDA approves Rivfloza™ for children ≥9 years old and adults living with primary hyperoxaluria type 1 (PH1), a rare genetic condition
Published: 2023-10-02 (Crawled : 17:00) - biospace.com/
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: -0.85%
H: 3.13%
C: 1.81%
fda rare children genetic living
OnKure Therapeutics Appoints Ann Howell, Pharm.D., as Vice President of Regulatory Affairs
Published: 2023-09-20 (Crawled : 17:00) - biospace.com/
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: 1.26%
H: 1.82%
C: 0.03%
therapeutics
Rallybio Announces Succession Plan; Appoints Stephen Uden, M.D., as Chief Executive Officer, Effective August 1, 2023
Published: 2023-06-29 (Crawled : 12:20) - biospace.com/
AZNCF | $135.305 -4.19% 1.1K
|
Health Technology
|
| O: 1.06%
H: 0.72%
C: 0.72%
RLYB | News | $1.74 -3.33% -3.45% 520K
|
|
| O: -0.34%
H: 4.41%
C: -5.25%
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: -1.19%
H: 1.41%
C: 1.36%
CRL | $230.09 -0.97% 0.0% 500K
|
Commercial Services
|
| O: 0.09%
H: 1.73%
C: 1.58%
AZN | $68.53 0.39% 0.39% 3.7M
|
Health Technology
|
| O: -0.83%
H: 0.89%
C: 0.68%
Beta Bionics Announces FDA Clearance for the Use of a Prefilled Insulin Cartridge With the iLet Bionic Pancreas
Published: 2023-06-22 (Crawled : 14:00) - biospace.com/
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: -0.45%
H: 0.89%
C: 0.13%
fda pancreas clearance insulin
Ray Therapeutics Closes Oversubscribed $100M Series A Financing to Advance Optogenetic Gene Therapies for Blinding Diseases
Published: 2023-05-16 (Crawled : 14:00) - biospace.com/
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: -1.48%
H: 1.06%
C: 0.44%
ray therapeutics
Ocelot Bio Appoints Lise Kjems, M.D., Ph.D., as Chief Medical Officer
Published: 2023-04-18 (Crawled : 14:00) - biospace.com/
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: -0.66%
H: 0.71%
C: -0.09%
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: -0.86%
H: 0.27%
C: -1.97%
medical
Innate Pharma Announces Conference Call and Webcast for Full Year 2022 Financial Results
Published: 2023-03-16 (Crawled : 07:00) - biospace.com/
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -0.07%
H: 1.96%
C: 0.56%
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: -1.4%
H: 0.03%
C: -0.08%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 1.01%
H: 0.0%
C: 0.0%
IPHA | $2.35 -9.27% -10.21% 16K
|
Health Technology
|
| O: -6.11%
H: 3.54%
C: 0.69%
pharma conference year financial
Novo Nordisk to lower U.S. prices of several pre-filled insulin pens and vials up to 75% for people living with diabetes in January 2024
Published: 2023-03-14 (Crawled : 19:00) - biospace.com/
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: 1.15%
H: 0.65%
C: 0.56%
diabetes living insulin
Innate Pharma Provides Update on Silicon Valley Bank Exposure
Published: 2023-03-13 (Crawled : 09:00) - biospace.com/
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: -0.02%
H: 1.44%
C: -0.51%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -0.81%
H: 0.0%
C: 0.0%
IPHA | $2.35 -9.27% -10.21% 16K
|
Health Technology
|
| O: 2.21%
H: 4.65%
C: -1.66%
pharma update
Zealand Pharma Announces Full Year Results for 2022
Published: 2023-03-02 (Crawled : 08:00) - biospace.com/
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: -0.53%
H: 1.28%
C: 1.06%
pharma year
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.